Chari D. Mukhopadhyay Pathogenesis of pan- creatic cancer exosome-induced lipolysis in adipose tissue Gut 65 2016 1165-1174 G. Ding L. Zhou Y. Qian M. Fu J. Chen J. Chen J. Xiang Z. Wu G. Jiang L. CaoM.P.

Plasma membrane-derived EVs secreted from the parent cell strengthens some but not all plasma membrane proteins and those that integrated inside EVs conserve the topology of the parent cell plasma membrane .The function of EVs appears to be dependent on their cargo.

The mechanisms of RNA and miRNA selection by EVs are poorlyTable 2Circulating microvesicles between 200 and 2000 nm in gastrointestinal cancers.Cancer typeCancer subtypeEVs sourceEVs sizeDetection and purificationmethodsSubpopulations of EVsPotential biomarkersRef.Colorectal cancersCRC and PCHuman serumNDFCMEpCAM EpCAMCD147 CD147EpCAM-MVsIncreased EpCAM CD147CRCPlatelet-poor plasmaNDFCMCRC-derived MVsNDCRCSolid tissue surgically orendoscopically resected 1000 nmRT-PCR NTACRC-derived MVsmiR-1246CRCHuman plasma 1000 nmFCMTEVsND Colon cancerBone marrowNDFCMCD34HER2neu stem cell EVsND Colon cancerHuman body fluids pleural liquid 20-2000 nmSEMMVs PEVsNDCRCHuman plasma 1000 nmFCMTF PS EVsD-dimer to detect VYE inCRC patientsGastrointestinal cancers Gastric cancer III-IV stageHuman plasmaNDCentrifugation FCMprocoagulant activityLeukocyte-derived MVs Er-derived MVs Endo-derived MVs PS MVsLeukocyte MVs Er MVs Endo MVs  In GC III-IV patients PS MVsGastric cancerHuman plasma10-800 nmTEM FCM AFMTEVs PEVsCCR6 and HER2neu Human plasmaNDFCMCirculating tumor-derived EVsNDGastric cancerHuman plateletNDFCMPEVsNDPancreatic cancersHuman pancreatic adenocarcinoma celllines BxPc-3 and Low.6plTF MVs from PC injected in Par4- deficient miceNDFCMTF MVsTF MVs for PC-associated thrombosisCRC PC IBDPlatelet-poor plasmaNDFCMPMPs EMPs Er-derived MVs LeuMVs TFFibrin CEA CA19-9 MVsSpecific signaturePancreatic cancer with associated thrombosisNDFCMCD31 CD68 AnnV TF total AnnVAnnV Muc1TF MVs for PC-associated thrombosisPancreatic cancer with associated thrombosis IVC-stenosis mice modelPanc02 pancreatic ductal cell line induced in C57Bl6 miceNDCentrifugation FCMTFNDPancreatic carcinomaHuman blood200-2000 nm SEMMVs PEVsND ND -  300 nm in the studies where conventional flow cytometry FCM was used for characterization of MVs standard limit of sensitivity for conventional flow cytometer.Table 3Characterization of EVs derived from human cell lines.Cancer typeCancer subtypeEVs sourceEVs sizeDetection and purification methodsSubpopulations of EVsPotential biomarkersRef.ColorectalcancersColorectal carcinomaHCT-8NDTEMFraction obtained with exosome- precipitation solutionmiR-210Colorectal carcinomaSW480ND0.22 mkm filtration and differentialultracentrifugation western blotting microarray functional assays qRT-PCRFraction obtained from 48 h cultural supernatantErk12 kinase dependent internalizationColorectal carcinomaSW480NDDifferential ultracentrifugation single molecule-localization microscopy SMLM real-time PCR FCM western blotting48-72 h exosomal EX fractionsmiR31Colorectal carcinoma and pancreatic carcinomaSW480 A818.4 Capan1NDDifferential ultracentrifugation FCM zymography RT-PCRCD44v6Colorectal carcinomaHT-29 Caco-2 in vivomouse model30-150 nm TEMDifferential ultracentrifugation and EXpurification kit TEM FCM western blotting HSP70 qRT-PCR functional assaysEX fraction from 24 and 48 h supernatantCXCR4-axisColorectal carcinomaLIM1863Different 30-100 nm 30-1000 nm fractionsSequential ultrafiltration 0.1 0.22 0.450.65 mkm cryo-EMEX and MVs fractionsDifferent proteomic signatures for EX and MVsMurine colorectal carcinoma CT26 murine colorectalcarcinoma associated with mouse macrophage Ana-1 cell lineDifferential ultracentrifugation ExoQuicktm TEM NTA western blotting mass-spectrometry qRT-PCREX fraction obtained from cultural supernatant of MF associated with gastric cancer cellsProteomic signaturesColorectal carcinomaDLD-1 and DLD-15FU50-450 nmNTA RT-PCRDLD-1 and DLD-15FU-derived MVsmiR-34a miR-145Colorectal carcinomaLIM186350-150 nm EX and 100-1500 nm MVsUltracentrifugation and column separation qRT- PCR western blotting CD9 deep RNA sequencingA33-EX and EpCam EX and MVs32-miRNA signatureColorectal carcinomaHCT-116 100 nmDifferential ultracentrifugation TEM NTA Acheassay western blottingCD9 and CD63 exosomal fractionColorectal carcinomaDLD-1 WiDr SW480 andCOLO201Colorectal carcinomaHCT116 HCT15 HT29COLO201 COLO205 WiDr SW111630-200 nmNTA western blottingDLD-1 WiDr SW480 and COLO201 exosomes 100 nmExoScreen immunoblot NTAHCT116 HCT15 HT29 COLO201COLO205 WiDr SW1116 exosomesmiR-1246 TGF-bCD147CD9 CA19-9Colorectal carcinomaLIM1215 100 nmUltracentrifugation and 0.1 mkm filtrationimmunoprecipitation western blotting LC-MS MSLIM1215-derived fractionCadherin17Colorectal carcinomaSw480 and SW62040-130 nmEM Cryo-EM GeLC-MSMSSw480 SW620 secretome andexosomesTSG101 Alix CD63 MET S100A8 S100A9 TNC FNB2 EGFR JAG1 SRC TNIK CAV1 FLOT1 FLOT2 PROM1Colorectal carcinomaHT2990 nm to 812 nmNTA TEM FCM western blottingHT29 cell line-derived EVsCEACAMsColorectal carcinomaMurine LIM1863 100 nm TEMUltracentrifugation combined with filtrationhA33EpCam immunoaffinity purification western blotting TSG101 Alix EpCam A33 TEM Gel C-MSMSEX immunoaffinity purified fractionColorectal carcinomaHCT15 SW480 and WiDrCRC 220 nmSDS-PAGE western blotting RT-PCRHT15 SW480 and WiDr-derived EVs CD63 CD9 and CD81 miR-21Colorectal carcinomaSW480 and SW62023 to 636 nm and26-574 nm defined by NTATEM Nano-LC-ESI-MSMS NTA peptide OFFGEL fractionationSW480 and SW620-derived EVsTetraspanin and their associatedproteins FSCN1 STRAP S100A4 S100A14 expressionColorectal carcinomaHCT116NDFCM RT-PCR western blottingHCT116 EX fractionTSAP6Colorectal carcinomaSW948 SW620 SW480HT29 CaCo2NDMALDI-TOFTOF-MS nano-HPLCESI-MSMS 2DGESW948 SW620 SW480 HT29CaCo2 secretomes and EX fractionGlod4 Rad23bC-terminal fragment of agrinColorectal carcinomaLIM1215 200 nmFiltration and differential centrifugation andimmunocapture purification A33 TEM IEM CD63 LS-MSMSA33 EX-fractionProteome analysisColorectal carcinoma andCX2 and Colo357 200 nmFiltration and Differential centrifugation IEMEX fractionHSP70 Bag4 active fractioncontinued on next pageTable 3 continuedCancer typeCancer subtypeEVs sourceEVs sizeDetection and purification methodsSubpopulations of EVsPotential biomarkersRef.pancreas carcinomaHSP70 western blotting FCM functionalassaysColorectal carcinomaSW48040-150 nmMicroarray TEM IHC RT-PCRSW480 CRC cell line-derived EXfractionCENPE KIF15 CEP55 CCNA2 NEK2 PBK and CDK8Colorectal carcinomaSW403 and CRC2846250-100 nmFCM western blotting IEMFasL TRAIL CD63 and CEACRC MVsCEA and CD63Colorectal carcinomaHT29-19A and T84- DRB10401CIITA30-90 nmIEM FCM MALDI-TOF-MSApical and basolateral EX fractionCD63 and CD26EsophagealcancersEsophageal squamous cell carcinomaEC9706NDDifferential centrifugationEX fraction from 48-h cellsupernatantEsophageal squamous cell carcinomaTE2 Murine SCCVIINDExosome-isolation kit Invitrogen qRT-PCR AchE quantitationCD63-GFP-tagged exosomes from TE2CD63Esophageal carcinomaEC970630-60 nmTEM Solexa RT-PCREC9706 EX fractionlet-7 family miR-21-5p miR-26a-5pCo-culture esophageal carcinoma and fibroblasts Co-culture esophageal carcinoma and fibroblastsKYSE-30NDDifferential centrifugationEX fraction from conditionedmediumTE1 TE2 TE4 TE6 TE11NDDifferential ultracentrifugationEX fraction from 48-h cellsupernatantUpregulation of 18 miRNAmiR-1246Esophageal adeno-carcinoma Het-1ANDLSCM FCMHet-1A EX fractionCD95L Gastric cancerGastric cancerGES-1 MGS-803 SGC-790124-340 nmNTATEM IFC48 h supernatants fractionNDGastric carcinomaSGC-7901 also co-cultured with HUVEC 100 nm TEMDifferential centrifugation TEM ELISA qRT-PCR functional assays immunohistochemistry CD31 anti-VEGF western blotting anti-Bim anti-GAPDHCultural supernatant EX fractionmiR-29acGastric cancerMKN-1-7-45-74NDDifferential ultracentrifugation qRT-PCRwestern blotting tetraspanin-8 RNAi functional methods48 h supernatants MVs fractionTSPAN8 prognostic markerGastric cancerSCG-901 50 nm TEMDifferential ultracentrifugation and filtration0.20 mkm TEM FCM functional assays microRNA microarray western blotting CD9 HSP70EX fraction from 48 h cultural supernatantsCD97Gastric cancerGC415Range 60-900 nm highest conc.80-120 nmDifferential ultracentrifugation FCM DLS NTA AFM functional assaysFractions from supernatants confluent cell culturesCD44 CD44v6 CCR6 HER- 2Scirrhous gastric carcinoma cell line and gastric cancer peritoneal lavagesOCUM-2 M 2 M-D30.22 mm filtration and differential ultracentrifugation miRNA microarray qRT-PCREX fraction from supernatantmiR-320c miR-1202 miR-1225-5p miR-1207-5p miR-7270signature validated in peritoneal lavagesDuodenal cancerPrimary AZ-521 HuTu-80 metastatic AZ-P7aNDLC-MSMS RT-PCRAZ-521 HuTu80 AZ-P7a EXfractionPABP1Gastric cancerGC-MSC GCN-MSC BM-MSC from tissue samplesGastric cancerSGC7901 HGC27 and gastric epithelial cellsND0.22 mm filtration and differential ultracentrifugation and ExoQuicktm miRNA microarray analysis qRT-PCR functional assays40-100 nm TEMDifferential ultracentrifugation TEM westernblotting CD9 CD81 TGFb VEGF N-cadherin E- cadherin GAPDH qRT-PCR functional assaysMSC-derived EX fractionmiR-214 miR-221 miR-222EX fractionND8 gastric cancer 5 colon cancer 9 pancreas cell linesMost of experiments with gastric cancer AZ-P7a cell lineDefined by IEMCentrifugation and filtration immunoelectronmicroscopy western blotting CD29 Alip1Alix Tsg101 miRNA profiling and microarray analysisCD63 EX fraction after combination of centrifugation and filtrationLet-7 miRNA familyGastric cancerSGC7901 BGC82330-100 nmEM western blottingSGC7901 BGC823 exosomesCbl-b Cbl-cPancreaticcancersPancreatic stellate cellsImmortalized pancreaticcancer cells30-110 nmDifferential ultracentrifugation TEM westernblotting CD9 63 81 GM130 Real-time PCR functional assaysCD9 CD63 CD81 GM130-EXfraction from conditioned mediaIncreased miR451Pancreatic cancerPC patient-derived cell linesNTA dataUltracentrifugation NTA western blottingCD63 TSG101 and ALIX exosomalNDcontinued on next pageTable 3 continuedCancer typeCancer subtypeEVs sourceEVs sizeDetection and purification methodsSubpopulations of EVsPotential biomarkersRef.Pancreatic ductal adenocarcinoma PDACmarkers confirmedBxPC-3 and HPAF-II100 nmEM FCM NTAPDAC-derived EX fractionNDPancreatic adenocarcinoma and epithelioid carcinomaPANC-1 SW1990 BxPC-330-110 nmNTA RT-PCR FISHPANC-1 SW1990 BxPC-3 derived EXfractionRFXAP miR-212-3pPDACAsPC-1 BxPC-3 PANC-150-120 nmSEM LSPR-based sensing platformCell lines-derived EX fractionmiR-10b Pancreatic carcinomaPanc-1 MIA Paca2 T3M4 100 nmEM FCM UPLC-MS RT-PCRPanc-1 MIA Paca2 T3M4 EX fraction GPC1 PDACPANC-140-150 nmUltracentrifugation AcH activity NTA DLSPANC-1-derived EX fractionNDbxPC-3 SWUltracentrifugationmiR155 Pancreatic adenocarcinomaINS-1 HPDE PANC-1 100 nmNTA EM CM SEMPC-derived EX fractionCA19-9 and AMPancreatic adenocarcinomaPaca44 Panc1 BxPc3MiaPaca2 HPSC and HPDE 100 nmTEM LC-MSPaca44 Panc1 BxPc3 MiaPaca2 HPSC and HPDE EX fractionMET CIT MAP4K4 Yes1 DDR1 WEE1 SRC CDCP1 TCSFPancreatic epithelioid carcinomaPanc-130-100 nmRT-PCR EM western blottingPanc-1-derived EX fractionmiR-203Pancreatic cancerPanc02 cells cultivated and injected in mice60-100 nmMagnetic bead-based exosome extraction AchE-assay TEM mRNA detectionmeasurementEX fraction purified with magnetic beads coated with biotinylated lectin specific to 26-linked sialic acid sandwichASPN Foxp1 Apbb1ip BC031781 Daf2 Gng2 IncenpPancreatic cancerAsPC1 BxPC3 Capan1 Capan2 MiaPaca1 Panc1 Pt45P1 8.18 HD3522 HD3542 HD3577FCM functional assaysEX fraction purified by ultracentrifugationTspan8 CD44v6 alpha6beta4Pancreatic cancerBxPC3 MiaPaca2 Panc1NDUltrafiltration and ultracentrifugation westernblotting ESI-MSMSEX fraction was enriched for EX marker proteins Alix CD9 Lamp3 synteninEGFRRat pancreatic adenocarcinomaBSp73ASMLNDUltracentrifugation SDS-PAGE western blotting MALDI-TOFEX fractionCD44v6-dependent exosomesPancreatic cancerSOJ-6 BxPC-3 MiaPaCa-2 and Panc-134-45 nmEM SDS-PAGE MALDI-TOFSOJ-6 BxPC-3 MiaPaCa-2 and Panc-1 nanoparticlesNDunderstood however there are indications that uncoded regions of RNA are involved in this process .

The luminal liquid contains high quantities of EVs of different origin EVs produced by cells structuring intestinal wall bacterial outer membrane vesicles EVs coming from parasites and food .EV fraction  500 nm size from colonic luminal fluid aspiratesfrom patients with IBD contained CD63CD66b originated from neutrophils and CD63MUC-1 originated from epithelium sub- populations though no statistical significance with healthy controls was found 8.5 vs 10.8 and 39.5 vs 47.4.

EVs of different origins vary in their stability but reported serum EVs and EVs associated with DNA may remain stable between 4 degC and room temperature for  24 h  which is important for cancer di- agnostics.

Production of EVs in intestinal lumina intraluminal EVs tumor cell-derived-EVs parasite-derived EVs bacterial OMVs.Lamina propriaFig.

Thus DNA me- thylation of ADAM metalloproteinase and basonuclin in serum appears to have prognostic value for pancreatic cancer .However tumor evolution and EVs modulating effects on GI cancers are always considered from the point of EVs originating only from eukaryotic cells and therefore completely neglects EVs originating from human microbiota.EVs originated from gastrointestinal cancer and human microbiotaGut microbiota play a crucial role in the pathogenesis of mucosal inflammation in GI tract disorders.

Sjostrand S. Gabrielsson J. Lotvall H. Valadi Human saliva plasma and breast milk exosomes contain RNA uptake by macrophages J. Transl.

Ding J. Xu J. Qian Z. Huang T. Wang D. Zhu Y. Shu P. Liu Diagnostic value of a plasma microRNA signature in gastric cancer a microRNA expression ana- lysis Sci Rep 5 2015 11251 H. Zhong Y. Yang S. Ma F. Xiu Z. Cai H. Zhao L. Du Induction of a tumour- specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients Int.

Cancer 136 2015 2616-2627 R. Que G. Ding J. Chen L. Cao Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma World J. Surg.

